XGEN Venture
Overview
XGEN Venture is a venture capital firm based in Milan, Italy, specializing in early-stage life sciences investments. It focuses on biotechnology, medical devices, diagnostics, and digital health. The firm was established in 2021 by the former team of Genextra, an Italian life sciences investment company. XGEN Venture invests primarily in European companies, with a significant number of portfolio companies originating from Italian research institutes. The firm's first fund, XGEN Venture Life Sciences Fund, closed in December 2024 at approximately €180 million.
Portfolio Companies
12
Website
xgenventure.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Nouscom | Oct 2026 | Series D | Co-investor |
| Aptadir Therapeutics | Sep 2026 | Seed | Co-investor |
| Dialybrid S.r.l. | Sep 2026 | Series A | Lead |
| EpilepsyGTx | Dec 2025 | Series A | Lead |
| AAVantgarde Bio | Nov 2025 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is XGEN Venture based?
XGEN Venture is headquartered in Milan, Lombardy, Italy.
When was XGEN Venture founded?
Founding year information for XGEN Venture is not publicly available.
How many portfolio companies does XGEN Venture have?
XGEN Venture has 12 portfolio companies in Caplight's dataset.
What are some companies in XGEN Venture's portfolio?
Recent investments visible on Caplight include Nouscom, Aptadir Therapeutics, Dialybrid S.r.l., EpilepsyGTx, AAVantgarde Bio.
What was XGEN Venture's most recent investment?
XGEN Venture's most recent investment on Caplight was in Nouscom in 2026.
What sectors does XGEN Venture focus on?
XGEN Venture focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does XGEN Venture focus on?
XGEN Venture typically invests at the Mid stage.
What is XGEN Venture's AUM?
XGEN Venture's assets under management are estimated between $190.0M and $190.0M.